Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Policy Tracker

Full Bill Tracker

Every tracked proposal: pending, failed, superseded, stalled and enacted — across psychedelics, cannabis, kratom and 7-OH.

Guyana

Bills tracked for this country and its states or regions.

2 of 2 tracked bills · newest recorded action first

  • Guyana · Cannabis
    Status not recorded
    12/2021

    Narcotic Drugs and Psychotropic Substances (Control) (Amendment) (No. 2) Bill 2021

    1. IntroducedJun 10, 2021 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    No dated action recorded

    Amendment bill relating to the narcotics-control law. No explicit psychedelics subject identified; legislative page lists passed.

    Bill source (opens in a new tab)
  • Guyana · Cannabis
    Status not recorded
    2/2021

    Narcotic Drugs and Psychotropic Substances (Control) (Amendment) Bill 2021

    1. IntroducedJan 28, 2021 (done)
    2. PassedNov 15, 2022 (done)
    3. SignedNov 15, 2022 (done)
    4. Law in effectNext step (current)

    No dated action recorded

    Amended penalties including removing custodial sentences for possession of up to 30 grams of cannabis. Cannabis bill, not psychedelic substances; assented 2022-11-15.

    Bill source (opens in a new tab)